Professor of Surgery, University Miami School of Medicine
General Surgery
Dr. Andreas G. Tzakis, MD
|
|
Give Review
Doctor Andreas G. Tzakis, MD is an expert in the field of General Surgery. He graduated from Mount Sinai School of Medicine. He over the years received 7 awards: "America's Top Doctors", "Top Doctors:South Florida", "SouthFloridaCEO: Top Doctors", "Miami Metro City Guide: Top Doctors", "Top Doctors: Florida", "Super Doctor" and "Fellow (FACS)". Andreas Tzakis is a published doctor and has 98 publications published. The lastest was: 'Role of Innate and Acquired Immune Mechanisms in Clinical Intestinal Transplant Rejection.' Andreas Tzakis is registered with Medicare and accepts Medicare payments.
Publications
- Role of Innate and Acquired Immune Mechanisms in Clinical Intestinal Transplant Rejection.
- Liver, Pancreas and Kidney Transplantation for the Treatment of Wolcott-Rallison Syndrome.
- Allogeneic uterus transplantation in baboons: surgical technique and challenges to long-term graft survival.
- Organ Shortage: The Greatest Challenge Facing Transplant Medicine.
- Excessive immunosuppression as a potential cause of poor survival in simultaneous liver-kidney transplantation for hepatitis C.
- Reply to Letter: "Liver Transplantation and Portal Vein Thrombosis: An Unfinished Saga"
- Multivisceral (cluster) transplants, their spinoffs, and uterine transplants.
- Liver natural killer cell inoculum for liver transplantation with hepatocellular carcinoma.
- When and Why Portal Vein Thrombosis Matters in Liver Transplantation: A Critical Audit of 174 Cases.
- The miracle of liver transplantation.
- Nonhuman primates as models for transplantation of the uterus.
- Portal vein arterialization using an accessory right hepatic artery in liver transplantation.
- Early recognition of alpha-1 antitrypsin deficiency and considerations for liver transplantation.
- Mannose binding lectin (mbl2) haplotype frequencies in solid organ transplant patients and correlation with MBL protein levels - Evaluation of complement-mediated effe...
- Citrulline level is a potent indicator of acute rejection in the long term following pediatric intestinal/multivisceral transplantation.
- Predisposing factors of diminished survival in simultaneous liver/kidney transplantation.
- Tregs expanded in vivo by TNFRSF25 agonists promote cardiac allograft survival.
- Use of bilateral anterior rectus fascia turnover method and components separation method for a difficult abdominal closure after transplantation.
- Peripheral blood gene expression analysis in intestinal transplantation: a feasibility study for detecting novel candidate biomarkers of graft rejection.
- Quantitative In Situ Analysis of FoxP3? T Regulatory Cells on Transplant Tissue Using Laser Scanning Cytometry.
- Is surgical resection superior to transplantation in the treatment of hepatocellular carcinoma?
- The Effect of Donor-Recipient Cytomegalovirus Serology on Adult Liver Transplantation: A Single Center Experience.
- Association Between Donor-Specific Antibodies and Acute Rejection and Resolution in Small Bowel and Multivisceral Transplantation.
- Devastating intracardiac and aortic thrombosis: a case report of apparent catastrophic antiphospholipid syndrome during liver transplantation.
- Graft-versus-host Disease after intestinal and multivisceral transplantation.
- Human liver cells expressing albumin and mesenchymal characteristics give rise to insulin-producing cells.
- Long-term follow-up of 23 operational tolerant liver transplant recipients.
- Liver transplantation for hepatocellular carcinoma in the model for end-stage liver Disease era.
- Effect of liver transplantation on spleen size, collateral veins, and platelet counts.
- Propylthiouracil-induced acute liver failure: role of liver transplantation.
- Differential transcriptome patterns for acute cellular rejection in recipients with recurrent hepatitis C after liver transplantation.
- Liver retransplantation of more than two grafts for recurrent failure.
- Small bowel transplantation: technical advances/updates.
- Successful treatment with bortezomib of a refractory humoral rejection of the intestine after multivisceral transplantation.
- Aortohepatic conduits: a personal commentary.
- Simvastatin-ezetimibe-induced hepatic failure necessitating liver transplantation.
- Analysis of acute and chronic rejection in multiple organ allografts from retransplantation and autopsy cases of multivisceral transplantation.
- Fecal calprotectin level measurements in small bowel allograft monitoring: a pilot study.
- Rescue of acute complete portal vein occlusion with Doppler ultrasound findings after liver transplantation.
- Blood citrulline level is an exclusionary marker for significant acute rejection after intestinal transplantation.
- Subclinical rejection in the initial postoperative period in small intestinal transplantation: a negative influence on graft survival.
- Gastroduodenal artery as the inflow tract to repair the right hepatic artery in a combined vasculobiliary injury after laparoscopic cholecystectomy.
- Transplantation of the spleen: effect of splenic allograft in human multivisceral transplantation.
- Alloimmunization to red cell antigens in liver and multivisceral transplant patients.
- The effect of immunosuppression on peritoneal adhesions formation after small bowel transplantation in rats.
- A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation.
- Medical mystery.
- Intestinal and multivisceral transplantation: future perspectives.
- Induction of auto-reactive regulatory T cells by stimulation with immature autologous dendritic cells.
- Negative impact of new-onset diabetes mellitus on patient and graft survival after liver transplantation: Long-term follow up.
- Does the heterozygous state of alpha-1 antitrypsin deficiency have a role in chronic liver Diseases? Interim results of a large case-control study.
- Intestinal and multivisceral transplantation in children.
- The importance of analyzing graft and patient survival by cause of failure: an example using pediatric small intestine transplant data.
- Simultaneous antibody-mediated rejection of multiple allografts in modified multivisceral transplantation.
- Utilization of dried blood spot citrulline level as a noninvasive method for monitoring graft function following intestinal transplantation.
- Intestinal transplantation for the treatment of neoplastic Disease.
- Intestinal and multivisceral transplantation in children with severe gastrointestinal dysmotility.
- 100 multivisceral transplants at a single center.
- A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring.
- Analysis of vascular access in intestinal transplant recipients using the Miami classification from the VIIIth International Small Bowel Transplant Symposium.
- Campath-1H does not alter bone marrow cell regulatory function.
- Use of a bioengineered skin equivalent for the management of difficult skin defects after pediatric multivisceral transplantation.
- Intrahepatic biliary strictures without hepatic artery thrombosis after liver transplantation: an analysis of 1,113 liver transplantations at a single center.
- Tenofovir therapy for lamivudine resistance following liver transplantation.
- Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection.
- Response of factor V inhibitor to rituximab in a patient who received liver transplantation for primary biliary cirrhosis.
- Outcomes in liver transplant recipients with hepatitis B virus: resistance and recurrence patterns from a large transplant center over the last decade.
- Sirolimus-associated hepatotoxicity in liver transplantation.
- Use of a living dermal equivalent for a refractory abdominal defect after pediatric multivisceral transplantation.
- Cavoatrial shunt in the treatment of suprahepatic vena cava stricture after liver transplantation.
- Noncomposite simultaneous liver and intestinal transplantation.
- The use of Campath-1H as induction therapy in renal transplantation: preliminary results.
- A retrospective review of liver transplant patients treated with sirolimus from a single center: an analysis of sirolimus-related complications.
- Multi-organ procurement and successful multi-center allocation using rapid en bloc technique from a controlled non-heart-beating donor.
- Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and rib...
- Preliminary experience with alemtuzumab (Campath-1H) and low-dose tacrolimus immunosuppression in adult liver transplantation.
- Intestinal and multivisceral transplantation after abdominal trauma.
- Viral interleukin-10-engineered autologous hematopoietic stem cell therapy: a novel gene therapy approach to prevent graft rejection.
- Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
- Anastomotic healing in a small bowel transplantation model in the rat.
- Current status of small bowel transplantation in children: update 2003.
- Partial abdominal evisceration, ex vivo resection, and intestinal autotransplantation for the treatment of pathologic lesions of the root of the mesentery.
- Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers.
- The impact of donor chemical overdose on the outcome of liver transplantation.
- Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation.
- A retrospective review of sirolimus (Rapamune) therapy in orthotopic liver transplant recipients diagnosed with chronic rejection.
- Expression of MUC2 and MUC4 proteins and cytokines: early markers of intestinal graft rejection.
- Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.
- Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine.
- Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver Disease.
- Human donor bone marrow cells induce in vitro "suppressor T cells" that functionally suppress autologous B cells.
- Portal versus systemic drainage of small bowel allografts: comparative assessment of survival, function, rejection, and bacterial translocation.
- Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients.
- Successful treatment of posttransplant lymphoproliferative Disease with prolonged rituximab treatment in intestinal transplant recipients.
- Regulation of alloimmune responses (GvH reactions) in vitro by autologous donor bone marrow cell preparation used in clinical organ transplantation.
- Acquired hyperplastic gastric polyps in solid organ transplant patients.
- Effect of living-related donor bone marrow infusion on chimerism and in vitro immunoregulatory activity in kidney transplant recipients.
Schools
University Of Athens School Of Health Sciences
Mt Sinai Hospital
SUNY Stony Brook
University Of Pittsburgh Med Center
Procedures Preformed
- Liver Transplant
- Transplant Surgery
Conditions Treated
- Hepatobiliary Cancer
- Pancreatic Cancer
- Pancreatic Disease
Doctors Specialties
- General Surgery
- Transplant Surgery
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:South Florida
- SouthFloridaCEO: Top Doctors
- Miami Metro City Guide: Top Doctors
- Top Doctors: Florida
- Super Doctor
- Fellow (FACS)
Education
-
University of Pittsburgh Medical Center -
SUNY Stony Brook University Hospital & Medical Center -
Mount Sinai School of Medicine -
University of Athens
Hospital
-
University of Miami Hospital -
Miami Veterans Affairs Healthcare System -
Cleveland Clinic -
Cleveland Clinic Florida
Drug Facts
| NPI NUMBER | 1427013218 | |
| NPPES Provider LastName | TZAKIS | |
| NPPES Provider FirstName | ANDREAS | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | General Surgery | |
| Total Claim Count | 2976.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1427013218 |
| Last Name Of The Provider | TZAKIS |
| First Name Of The Provider | ANDREAS |
| View All |
Similar Doctors
|
Dr. Steven D. Wexner, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Mark Grove, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mark E. Sesto, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Fernando M. Safdie, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Melissa J. Watson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rama Rao Ganga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James A. Flippin, MD |
|
|
Dr. Mayank Roy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Armando Rosales-Velderrain, MD
This Doctor is OpenDoctor Recommended.
|